Nomenclador OSEP
Listado de prácticas de la Obra Social de los Empleados Públicos
Se debe colocar el MDRD en todo informe de creatinina realizado a pacientes de OSEP (vigencia 01/10/2023). Calcular MDRD · Ver normas OSEP · Novedades OSEP
| Código | Descripción | UB | Tope | Vigencia |
|---|---|---|---|---|
| 0002 | ACETONURIA | 1 | — | 09/2026 |
| 0005 | ACIDO BASE PH REAL, POO2, E.B. Y BIC | 15 | — | 09/2026 |
| 0006 | ACTH PO R.I.E | 12 | — | 09/2026 |
| 0007 | ADDIS, RECUENTO DE | 2 | — | 09/2026 |
| 0009 | ADRENALINA, PLASMATICA (CATECOLAMINA PLA | 25 | — | 09/2026 |
| 0010 | ADRENALINA, URINARIA (CATECOLAMINA URINA | 25 | — | 09/2026 |
| 0014 | AGLUTININAS ABO. MEDIO SALINO | 3 | — | 09/2026 |
| 0015 | ALBUMINA | 1.5 | 6 Anual | 09/2026 |
| 0018 | ALDOLASA | 6 | — | 09/2026 |
| 0019 | ALDOSTERONA PLASMATICA R.I.E. | 15 | — | 09/2026 |
| 0020 | ALFAFETOPROTEINAS, R.I.E. | 10 | 4 Anual | 09/2026 |
| 0022 | AMILASEMIA | 4 | — | 09/2026 |
| 0023 | AMILASURIA | 4 | — | 09/2026 |
| 0025 | AMINOACIDEMIA FRACCIONADA P/CROMATOGRAF | 12.5 | — | 09/2026 |
| 0027 | AMINOACIDURIA FRACCIONADA P/CROMATOGRAF | 12.5 | — | 09/2026 |
| 0028 | AMNIOTICO,LIQUIDO,CELULAS NARANJAS | 1 | — | 09/2026 |
| 0029 | AMNIOTICO LIQ.ESPECTROFOTOM-TEST LISLEY | 5 | — | 09/2026 |
| 0030 | AMNIOTICO LIQ.REL.LECITINA/ESFINGOMIELI | 5 | — | 09/2026 |
| 0031 | AMONEMIA | 20 | — | 09/2026 |
| 0032 | AMP CICLICO POR R.I.E. | 15 | — | 09/2026 |
| 0033 | ANGIOTENSINA I O II, R.I.E.(c/u) | 30 | — | 09/2026 |
| 0034 | ANHIDRASA CARBONICA B ERITROCITARIA | 2 | — | 09/2026 |
| 0035 | ANTIBIOGRAMA | 6 | 6 Anual | 09/2026 |
| 0036 | ANTIBIOGRAMA BAC.DE KOCH-7 ANTIBIOTICOS | 60 | — | 09/2026 |
| 0040 | ANTICUERP.ANTIGLOMERULAR INMUN.FLUORESC | 6 | 2 Anual | 09/2026 |
| 0041 | ANTICUERPOS ANTIMEMBRANA BASAL,INM.FLUO | 6 | 2 Anual | 09/2026 |
| 0042 | ANTICUERP. ANTIMUSCULOSO LISO, INM.FLUO | 7 | 2 Anual | 09/2026 |
| 0043 | ANTICUERPOS,C/CEPA BACTERIANA AISLADA | 3 | — | 09/2026 |
| 0044 | ANT.ANTIFRA. MICROSOMAL IFI | 6 | — | 09/2026 |
| 0045 | Ac.ANTITIROPEROXIDASA (Ac.ATPO) | 12 | — | 09/2026 |
| 0046 | ANTICUERPO ANTITIROGLUBULINA, HEMOAGLU | 10 | 3 Anual | 09/2026 |
| 0049 | ANTIDESOXIRRIBONUCLEASA-ADENASA- | 9 | 3 Anual | 09/2026 |
| 0050 | ANTIESTAFILOLISINA | 3 | 3 Anual | 09/2026 |
| 0051 | ANTIESTREPTOLISINAS O | 6 | 4 Anual | 09/2026 |
| 0052 | ANTIESTREPTOQUINASA | 3 | — | 09/2026 |
| 0053 | ANTIFUNGICOS-PRUEBA DE SENSIBILIDAD | 15 | — | 09/2026 |
| 0054 | ANTIHIALURONIDASA | 4 | — | 09/2026 |
| 0055 | ANTIMITOCONDRIALES,ANTICUERP.INMUNOFLUO | 7 | 3 Anual | 09/2026 |
| 0056 | ANTINUCLEARES,ANTICUERP.INMUNOFLUORESC. | 7 | 3 Anual | 09/2026 |
| 0057 | ANTITRIPSINA,INMUNODIFUSION CUANTITATIV | 10 | — | 09/2026 |
| 0058 | ANTITROMBINA, TITULACION | 15 | — | 09/2026 |
| 0059 | ARSENICO | 20 | — | 09/2026 |
| 0060 | ASCORBICO ACIDO | 30 | — | 09/2026 |
| 0061 | AUTOVACUNA | 5 | — | 09/2026 |
| 0063 | ANTICUERPOS Anti-HIV(ELISA) | 11 | — | 09/2026 |
| 0101 | BACILOSCOPIA DIRECTA-ZIEHL NIELSEN | 4 | — | 09/2026 |
| 0102 | BACILOSCOPIA DIRECTA Y CULTIVO | 10 | — | 09/2026 |
| 0103 | BACILOSCOPIA P/INMUNOFLUORESCENCIA | 10 | — | 09/2026 |
| 0104 | BACTERIOLOGIA DIRECTA-GRAM- | 2 | — | 09/2026 |
| 0105 | BACTERIOLOGIA DIREC.Y CULT.C/IDENT.B.GE | 7 | — | 09/2026 |
| 0108 | BENCE-JONES, PROTEINAS DE. | 30 | — | 09/2026 |
| 0110 | BILIRRUBINEMIA TOTAL,DIRECTA E INDIRECT | 1.5 | — | 09/2026 |
| 0131 | CADENA LIVIANA, KAPPA Y LAMDA | 40 | — | 09/2026 |
| 0132 | CADMIO, TOXICO EN ORINA | 20 | — | 09/2026 |
| 0133 | CALCEMIA TOTAL | 1.5 | 6 Anual | 09/2026 |
| 0134 | CALCIO IONICO | 4 | 6 Anual | 09/2026 |
| 0136 | CALCIURIA | 2 | — | 09/2026 |
| 0137 | CALCITONINA PLASMATICA, R.I.E. | 16 | — | 09/2026 |
| 0138 | CALCULO URINARIO EXAMEN FISICOQUIMICO | 12 | 4 Anual | 09/2026 |
| 0140 | CARIOTIPO, MAPA CROMOSOMICO | 107 | 1 en vida | 09/2026 |
| 0141 | CAROTENO BETA, EN SANGRE | 22 | — | 09/2026 |
| 0144 | CEA (CARCINOEMBRIOGENICO) POR R.I.E. | 12.5 | — | 09/2026 |
| 0147 | CELULAS L.E. -SANGRE- | 7 | — | 09/2026 |
| 0148 | CELULAS NEOPLASICAS-liquidos,exudado,tra | 9 | — | 09/2026 |
| 0151 | CERULOPLASMINA | 6 | — | 09/2026 |
| 0152 | CETEGENOESTEROIDES URINARIOS | 5 | — | 09/2026 |
| 0154 | CETONEMIA | 1.5 | — | 09/2026 |
| 0157 | CETOESTEROIDES-17 NEUTROS URINARIOS TOT | 5 | — | 09/2026 |
| 0158 | CETOESTEROIDES-17, ESTIMULLACION C/ACTH | 5 | — | 09/2026 |
| 0159 | CETOESTEROIDES-17,INHIBICION C/DEXAMETA | 5 | — | 09/2026 |
| 0160 | CETO-17 INHB.C/DEXAMET.Y ESTIM.GONADOT | 5 | — | 09/2026 |
| 0161 | 17-CETOEST. Y 17 HIDROXI.EST.CACTH | 10 | — | 09/2026 |
| 0167 | CITRICO, ACIDO | 10 | — | 09/2026 |
| 0168 | CLORO PLASMATICO | 2 | 6 Anual | 09/2026 |
| 0169 | COAGULACION Y SANGRIA, TIEMPO DE | 1 | — | 09/2026 |
| 0170 | COAGULO, RETRACCION DEL | 1 | — | 09/2026 |
| 0171 | COAGULOGRAMA BASICO,-COD.887,746,169,77 | 7 | 1 dia | 09/2026 |
| 0172 | COBRE EN SANGRE | 20 | — | 09/2026 |
| 0173 | COCAINA | 17.5 | — | 09/2026 |
| 0174 | COLESTEROL | 1.5 | — | 09/2026 |
| 0177 | COMPATIBIL.RHOGAM SANGRE MAT.DU Y COOMB | 6 | — | 09/2026 |
| 0178 | COMPATIBILIDAD SANG.MATRIMON.2 ABO Y 2R | 5 | — | 09/2026 |
| 0179 | COMPLEMENTO, ACTIVIDAD TOTAL | 9 | — | 09/2026 |
| 0180 | COMPL.INMUNOQ.C10,C15,C3,C4,C5,C7,C8 C/ | 5 | 6 Anual | 09/2026 |
| 0181 | CONCENTRACION DE LIQUIDOS BIOLOGICOS | 28 | — | 09/2026 |
| 0184 | COOMBS DIRECTA, PRUEBA | 2 | — | 09/2026 |
| 0186 | COOMS INDIRECTA, CUANTITATIVA | 12 | — | 09/2026 |
| 0187 | COPROCULTIVO | 10 | — | 09/2026 |
| 0188 | COPROPORFIRINAS | 15 | — | 09/2026 |
| 0189 | CORTISOL PLASMATICO, R.I.E. | 10 | — | 09/2026 |
| 0190 | CREATINQUINASA-CPK | 3 | — | 09/2026 |
| 0191 | CREATINA, ORINA O SANGRE | 2 | — | 09/2026 |
| 0192 | CREATININA | 3 | — | 09/2026 |
| 0193 | CREATININA, CLEARENCE O DEPURACION | 5 | — | 09/2026 |
| 0194 | CRIOGLUTININA | 1 | — | 09/2026 |
| 0195 | CRIOGLOBULINAS | 1 | — | 09/2026 |
| 0196 | CROMATINA SEXUAL | 2 | — | 09/2026 |
| 0241 | CHAGAS, AGLUTINACION DIRECTA | 3 | — | 09/2026 |
| 0242 | CHAGAS, FIJACION DE COMPLEMENTO | 3 | 2 Anual | 09/2026 |
| 0243 | CHAGAS, Ac. Totales/IgG (IFI/ELISA/QL) | 8 | 2 Anual | 09/2026 |
| 0244 | CHAGAS,PARASITEMIA(gota gruesa,gota fres | 6 | 2 Anual | 09/2026 |
| 0261 | DAVIDSON DIFERENCIAL, PRUEBA DE. | 3 | — | 09/2026 |
| 0262 | DEHIDROEPIANDROSTERONA EN ORINA | 11 | 2 Anual | 09/2026 |
| 0264 | MATERIAL COMPLEMENTARIO DESCARTABLE | 1 | — | 09/2026 |
| 0268 | DIGOXIN (POR R.I.E.) | 15 | — | 09/2026 |
| 0272 | DOMICILIO, EXTRACCION A | 10 | — | 09/2026 |
| 0293 | EMBARAZO, REACCION INMUNOLOGICA PARA | 3.5 | — | 09/2026 |
| 0295 | EOSINOFILOS, RECUENTO DE. | 1 | — | 09/2026 |
| 0296 | ERITROBLASTOS, PORCENTAJE DE. | 1 | — | 09/2026 |
| 0297 | ERITROSEDIMENTACION | 1 | — | 09/2026 |
| 0298 | ESPERMOGRAMA BASICO (EIVE) | 28 | — | 09/2026 |
| 0300 | ESTRADIOL PLASMATICO POR R.I.E. | 10 | — | 09/2026 |
| 0301 | ESTRIOL URINARIO | 13 | — | 09/2026 |
| 0302 | ESTRIOL PLASMATICO,P/RADIOINMUNOENSAYO | 13 | — | 09/2026 |
| 0305 | ESTRONA serica | 15 | — | 09/2026 |
| 0307 | ETANOL, TOXICO EN SANGRE | 10 | — | 09/2026 |
| 0308 | EUGLOBULINAS, TEST DE. | 3 | — | 09/2026 |
| 0309 | EXUDADO NASOFARINGEO,INVESTIG.DE LOEFLE | 5 | 4 Anual | 09/2026 |
| 0331 | FACTOR DE COAGULACION V | 12 | — | 09/2026 |
| 0332 | FACTOR DE COAGULACION VII | 24 | — | 09/2026 |
| 0333 | FACTOR DE COAGULACION VIII | 20 | — | 09/2026 |
| 0334 | FACTOR DE COAGULACION IX | 20 | — | 09/2026 |
| 0335 | FACTOR DE COAGULACION X | 12 | — | 09/2026 |
| 0337 | FENIL-ALANINA | 30 | — | 09/2026 |
| 0340 | FENILPIRUVICO,ACIDO CUANTITATIVO ORINA | 10 | — | 09/2026 |
| 0342 | FENOTIAZINAS | 15 | — | 09/2026 |
| 0343 | FERREMIA-S 58,113 | 2 | — | 09/2026 |
| 0344 | FIBRINA, PRODUCTOS DE DEGRADACION -PDF- | 30 | — | 09/2026 |
| 0345 | FIBRINOGENO EN SANGRE | 4 | — | 09/2026 |
| 0349 | FISICO-QIM.EXAM.-ASP.CL,PROT,RIVALTA,G | 10 | — | 09/2026 |
| 0350 | FLUOREMIA | 10 | — | 09/2026 |
| 0351 | FLUORURIA | 10 | — | 09/2026 |
| 0352 | FOLICO, ACIDO | 11 | — | 09/2026 |
| 0353 | FONDO OSCURO | 4 | — | 09/2026 |
| 0354 | FORMULA LEUCOCITARIA | 1.5 | — | 09/2026 |
| 0355 | FOSFATASA ACIDA PRISTATICA | 5 | — | 09/2026 |
| 0356 | FOSFATASA ACIDA TOTAL | 3 | — | 09/2026 |
| 0357 | FOSFATASA ALCALINA | 1.5 | — | 09/2026 |
| 0358 | FOSFATASA ALCALINA CITOQUIMICA-GOMORI | 5 | — | 09/2026 |
| 0359 | FOSFATASA ALCALINA CITOQUIMICA-KAPLOW | 5 | — | 09/2026 |
| 0360 | FOSFATASA ALCALINA-TERMOESTABLE | 15 | — | 09/2026 |
| 0361 | FOSFATASA ALCALINA-ISOENZIMAS | 15 | — | 09/2026 |
| 0362 | FOSFATEMIA | 1.5 | — | 09/2026 |
| 0363 | FOSFATURIA | 1.5 | — | 09/2026 |
| 0366 | FOSFORO, CLEARENCE, DEPURACION DE. | 3 | — | 09/2026 |
| 0370 | FSH POR R.I.E. | 10 | — | 09/2026 |
| 0371 | FTA/ABS INMUNOFLUORESCENCIA | 8 | — | 09/2026 |
| 0373 | FUNCIONAL EXAMEN-MATERIA FECAL | 30 | — | 09/2026 |
| 0401 | GALACTOSA PRUEBA DE LA. | 8 | — | 09/2026 |
| 0402 | GALACTOSEMIA | 8 | — | 09/2026 |
| 0403 | GALACTOSURIA | 8 | — | 09/2026 |
| 0405 | GASTRINA PLASMATICA POR R.I.E. | 15 | — | 09/2026 |
| 0408 | GLOBULOS BLANCOS, RECUENTO Y FORMULA en | 3 | 6 Anual | 09/2026 |
| 0409 | GLOBULOS BLANCOS, RECUENTO DE. | 1 | 12 Anual | 09/2026 |
| 0410 | GLOBULOS ROJOS, RECUENTO DE. | 1 | 12 Anual | 09/2026 |
| 0412 | GLUCEMIA | 3 | — | 09/2026 |
| 0413 | GLUCEMIA CURVA DE. | 7.5 | — | 09/2026 |
| 0415 | GLUCOGENO, CITOQUIMICO | 4 | — | 09/2026 |
| 0420 | GLUTAMIL TRANSPEPTIDASA, GAMA | 2.5 | — | 09/2026 |
| 0428 | GONOCOCOS POR INMUNOFLUORESCENCIA | 5 | — | 09/2026 |
| 0430 | GRAHAM, TEST-SERIADO 7 DIAS CONS. | 3 | — | 09/2026 |
| 0432 | GRASAS,MATERIA FECAL,CUANTI-VAN DE KAME | 15 | — | 09/2026 |
| 0433 | GRUPO SANGUINEO | 5 | — | 09/2026 |
| 0463 | HAPTOGLOBINA INMUNODIFUSION CUANTITATIV | 9 | — | 09/2026 |
| 0464 | HEINS, CUERPO DE. | 3 | — | 09/2026 |
| 0465 | HEMATIES, RESISTENCIA GLOBULAR OSMOTICA | 10 | — | 09/2026 |
| 0466 | HEMATOCRITO | 1 | — | 09/2026 |
| 0467 | HEMOAGLUTINOGENOS A2,DU,ETC. C/DETERMIN | 4 | — | 09/2026 |
| 0468 | HEMOCULTIVO, AEROBIOS Y ANAEROBIOS | 10 | — | 09/2026 |
| 0470 | HEMOGLOBINA, DOSAJE DE. | 1 | — | 09/2026 |
| 0471 | HEMOGLOBINA, ELECTROFORESIS DE. | 11 | — | 09/2026 |
| 0472 | HEMOGLOBINA EN PLASMA | 4 | — | 09/2026 |
| 0474 | HEMOGLOBINA ALCALI RESISTENTE | 1 | — | 09/2026 |
| 0475 | HEMOGRAMA | 6 | — | 09/2026 |
| 0476 | HEMOLISINAS EN CALIENTE, TITULACION | 2 | — | 09/2026 |
| 0477 | HEMOLISINAS EN FRIO S/ANTICI.DONATH-LAN | 2 | — | 09/2026 |
| 0478 | HEMOPEXINA, INMUNODIFUSION CUANTITATIVA | 5 | — | 09/2026 |
| 0479 | HEMOSIDERINA urinaria | 9 | — | 09/2026 |
| 0480 | HEPARINA RESISTENTE A LA INVITRO | 15 | — | 09/2026 |
| 0481 | HEPATOGRAMA COMPLETO | 7.5 | — | 09/2026 |
| 0483 | HIDATIDOSIS HEMOAGLUTINACION | 4 | — | 09/2026 |
| 0484 | HIDATIDOSIS, TEST DEL LATEX | 10 | — | 09/2026 |
| 0486 | HIDROCORTICOIDES-17 EN ORINA | 5 | — | 09/2026 |
| 0487 | HIDROXINDOLACETICO, ACIDO | 10 | — | 09/2026 |
| 0488 | HIDROXIPOLINURIA | 12 | — | 09/2026 |
| 0492 | HOMOGENTISICO ACIDO-ORINA | 8 | — | 09/2026 |
| 0494 | HUDDLESSON, REACCION DE S 18 | 2 | — | 09/2026 |
| 0535 | INMUNOELECTROFORESIS | 10 | — | 09/2026 |
| 0536 | INMUNOELECTROFORESIS DE LIQ BIOL INC CO | 20 | — | 09/2026 |
| 0537 | INMUNOGLOBULINA A (Ig A) | 5 | 4 Anual | 09/2026 |
| 0538 | INMUNOGLOBULINA D (Ig D) | 15 | — | 09/2026 |
| 0539 | INMUNOGLOBULINA E (Ig E) | 10 | — | 09/2026 |
| 0540 | INMUNOGLOBULINA G (Ig G) | 5 | — | 09/2026 |
| 0541 | INMUNOGLOBULINA M (Ig M) | 5 | — | 09/2026 |
| 0543 | INSULINA | 11 | 4 Anual | 09/2026 |
| 0546 | IONOGRAMA SERICO | 3.5 | — | 09/2026 |
| 0547 | IONOGRAMA URINARIO | 3.5 | — | 09/2026 |
| 0592 | LACTICO, ACIDO ENZIMATICO | 10 | — | 09/2026 |
| 0594 | LACTICO DEHIDROGENASA LDH | 3 | — | 09/2026 |
| 0596 | LACTICO DEHIDROGENASA ISOENZIMAS P/ELEC | 6 | — | 09/2026 |
| 0597 | LACTOGENO PLACENTARIO,HORMONA POR R.I.E | 20 | — | 09/2026 |
| 0598 | LATEX ARTRITIS REUMATOIDEA | 5 | 4 Anual | 09/2026 |
| 0603 | LAZO, PRUEBA DE. | 1 | — | 09/2026 |
| 0610 | LEVULINICO DELTA, AMINO, ACIDO | 10 | — | 09/2026 |
| 0611 | LEVULINICO DELTA, AMINO DEHIDRATASA | 10 | — | 09/2026 |
| 0612 | LH POR R.I.E. | 10 | — | 09/2026 |
| 0613 | LIPASA EN SANGRE | 5 | — | 09/2026 |
| 0615 | LIPIDOGRAMA (ELECTROFORETICO) | 7 | 4 Anual | 09/2026 |
| 0619 | LIQUIDO CEFALORRAQUIDEO,FIS,WUI,CIT/BAC | 15 | — | 09/2026 |
| 0620 | LIQUIDO DE PUNCION,FIS,QUI,CITOL Y BAC | 15 | — | 09/2026 |
| 0622 | LISTERIAS, POR INMUNOFLUORESCENCIA | 9 | — | 09/2026 |
| 0623 | LITIO PLASMATICO | 6 | — | 09/2026 |
| 0652 | MACROGLOBULINA ALFA2,INMUNODIF.CUANTITA | 10 | — | 09/2026 |
| 0653 | MAGNESIO EN SANGRE | 2.5 | 4 Anual | 09/2026 |
| 0654 | MAGNESIO EN ORINA | 2.5 | 4 Anual | 09/2026 |
| 0656 | MANTOUX INTRODERMORREAC.TUBERCULINA OPP | 20 | — | 09/2026 |
| 0657 | MEDULOGRAMA | 9 | — | 09/2026 |
| 0660 | MERCURIO TOXICO EN ORINA | 15 | — | 09/2026 |
| 0662 | METANEFRINAS FRACCIONADAS URINARIAS | 25 | — | 09/2026 |
| 0663 | METANOL EN ORINA | 15 | — | 09/2026 |
| 0664 | MICOLOGIA, DIRECTO O COLORACION | 4 | — | 09/2026 |
| 0665 | MICOLOGIA, CULTIVO E IDENTIFICACION | 10 | — | 09/2026 |
| 0668 | MOCO NASAL, PH Y CITOLOGICO | 2 | — | 09/2026 |
| 0669 | MONONUCLEOSIS, TEST DE LATEX O MONOTEST | 3 | — | 09/2026 |
| 0670 | MONONUCLEOSIS,HEMOAGLUTINACION-P.BUNNEL | 3 | — | 09/2026 |
| 0695 | NORADRENALINA serica-CATECOLAMINA | 25 | — | 09/2026 |
| 0696 | NORADRENALINA urinaria-CATECOLAMINA | 25 | — | 09/2026 |
| 0702 | NUCLEOTIDASA | 4 | — | 09/2026 |
| 0711 | ORINA COMPLETA | 6 | — | 09/2026 |
| 0715 | OSMOLARIDAD, SUERO | 2.5 | — | 09/2026 |
| 0735 | PARASITOLOGICO DE MATERIA FECAL,2 MUEST | 2 | — | 09/2026 |
| 0736 | PARASITOLOGICO DE MATERIA FECAL SERIADO | 4 | — | 09/2026 |
| 0737 | PARASITOS HEMATICOS | 6 | — | 09/2026 |
| 0739 | PARATHORMONA,PLASMATICA P/RADIOINMUNOEN | 13.5 | — | 09/2026 |
| 0740 | PEROXIDASAS | 5 | — | 09/2026 |
| 0741 | PH | 2 | — | 09/2026 |
| 0746 | PLAQUETAS, RECUENTO DE. | 1 | — | 09/2026 |
| 0747 | PLASMA RECALCIFICADO, TIEMPO DE. | 1 | — | 09/2026 |
| 0748 | PLASMINOGENO,INMUNODIFUSION CUANTITATIV | 5 | — | 09/2026 |
| 0749 | PLOMO, EN ORINA | 20 | — | 09/2026 |
| 0751 | PORFIRINAS, EN ORINA | 15 | — | 09/2026 |
| 0758 | PROGESTERONA PLASMATICA P/RADIOINMUNOEN | 11 | — | 09/2026 |
| 0759 | PROLACTINA PLASMATICA P/RADIOINMUNOENSA | 10 | — | 09/2026 |
| 0761 | PROTEINA C REACTIVA | 5 | — | 09/2026 |
| 0763 | PROTEINAS TOTALES | 1.5 | 6 Anual | 09/2026 |
| 0764 | PROTEINOGRAMA EN ACETATO DE CELULOSA | 5 | — | 09/2026 |
| 0765 | PROTEINOGRAMA ELECTROFORETICO-LCR | 33 | — | 09/2026 |
| 0766 | PROTEINOGRAMA,LIQ.BIOL.NO INCLUYE CONC | 5 | — | 09/2026 |
| 0767 | PROTEINURIA | 1.5 | — | 09/2026 |
| 0768 | PROTOPORFIRINAS | 12 | — | 09/2026 |
| 0769 | PROTROMBINA, CONSUMO DE. | 2 | 12 Anual | 09/2026 |
| 0771 | PROTOMBINA TIEMPO | 2 | 12 Anual | 09/2026 |
| 0772 | PSEUDOCOLINESTERASA | 4 | — | 09/2026 |
| 0812 | RENINA ANGIOTENSINA PLAWMATICA POR R.I. | 18 | — | 09/2026 |
| 0815 | RH FACTOR C CHICA | 2 | — | 09/2026 |
| 0816 | RH FACTOR E GRANDE | 2 | — | 09/2026 |
| 0817 | RH FACTOR E CHICA | 2 | — | 09/2026 |
| 0818 | RETICULOCITOS, RECUENTO DE. | 2 | — | 09/2026 |
| 0820 | ROSSE RAGAN, PRUEBA DE. | 2.5 | — | 09/2026 |
| 0831 | SALICILATOS | 12.5 | — | 09/2026 |
| 0832 | SALMONELLA ANTICUERPOS INMUNOFLUORESCEN | 6 | — | 09/2026 |
| 0833 | SANGRE OCULTA EN MATERIA FECAL | 4 | — | 09/2026 |
| 0834 | SANGRE OCULTA materia fecal(SOMF)- inmun | 8 | — | 09/2026 |
| 0835 | SEROTONINA PLASMATICA POR R.I.E. | 24 | — | 09/2026 |
| 0837 | SIDEROFILINA CAPACIDAD DE SATURACION | 1 | — | 09/2026 |
| 0841 | SOMATOTROFINA PLASMATICA POR R.I.E. | 12 | — | 09/2026 |
| 0847 | SUDOR, TEST DE ELECTROLITOS | 15 | — | 09/2026 |
| 0863 | TESTOSTERONA PLASMATICA O URINARIA P/RI | 11 | — | 09/2026 |
| 0865 | TIROTROFINA PLASMATICA POR R.I.E. | 9 | — | 09/2026 |
| 0866 | TIROXINA TOTAL (T4) POR R.I.E. | 9 | — | 09/2026 |
| 0867 | TIROXINA EFECTIVA (ETR) POR R.I.E. | 9 | — | 09/2026 |
| 0870 | TOXOPLASMOSIS HERMOAGLUTINACION | 4 | — | 09/2026 |
| 0871 | TOXOPLASMOSIS INMUNOF. GAMMA ESPECIFICA | 6 | — | 09/2026 |
| 0873 | TRANSAMINASA GLUTANICO OXALECITICA | 1.5 | — | 09/2026 |
| 0874 | TRANSAMINASA GLUTAMICO PIRUVICA | 1.5 | — | 09/2026 |
| 0875 | TRANSFERRINA INMUNODIFUSION CUANTITATIV | 6 | — | 09/2026 |
| 0876 | TRIGLICERIDOS | 2.5 | — | 09/2026 |
| 0877 | TRIIODOTIRONINA (T3) UPTAKE POR R.I.E. | 9 | 12 Anual | 09/2026 |
| 0878 | TRIIODOTIRONINA TOTAL (TT3) POR R.I.E. | 9 | — | 09/2026 |
| 0880 | TROMBINA, TIEMPO DE. | 3 | 12 Anual | 09/2026 |
| 0887 | TTPC,TIEM.TROMBOPLAST.PARCI.CAOLIN KPTT | 2 | — | 09/2026 |
| 0901 | UREA, CLEARENCE | 3 | — | 09/2026 |
| 0902 | UREA | 1.5 | — | 09/2026 |
| 0903 | URETREAL, EXUDADO O FLUJO | 11 | — | 09/2026 |
| 0904 | ACIDO URICO EN SANGRE | 1.5 | — | 09/2026 |
| 0905 | URICO, ACIDO EN ORINA | 1.5 | — | 09/2026 |
| 0907 | UROCITOGRAMA, UNA MUESTRA | 4 | — | 09/2026 |
| 0931 | VAGINAL, EXUDADO O FLUJO | 16 | — | 09/2026 |
| 0932 | VANILLIN MANDELICO, ACIDO EN ORINA | 15 | — | 09/2026 |
| 0933 | V.D.R.L. CUALITATIVA | 2 | — | 09/2026 |
| 0934 | V.D.R.L. CUANTITATIVA | 4 | — | 09/2026 |
| 0937 | VITAMINA A | 37 | — | 09/2026 |
| 0938 | VITAMINA B12 | 15 | — | 09/2026 |
| 0939 | VITAMINA E | 37 | — | 09/2026 |
| 0953 | WIDAL, REACCION DE. | 4 | — | 09/2026 |
| 0971 | XILOSA-2, PRUEBA DE LA. | 6 | — | 09/2026 |
| 0981 | ZINC ERITROCITARIO | 12 | — | 09/2026 |
| 0982 | ZINC SERICO | 12 | — | 09/2026 |
| 0998 | CONSULTAS A BIOQUIMICOS | 5 | — | 09/2026 |
| 1001 | ACTO BIOQUIMICO DE INTERNACION | 6 | — | 09/2026 |
| 1020 | CHILAMIYDIAS PNEUMONIAE, Ac.Anti-Ig G | 18 | 3 Anual | 09/2026 |
| 1025 | CITOMEGALOVIRUS , Ac Anti IgG o Ac Total | 15 | — | 09/2026 |
| 1030 | CITOMEGALOVIRUS , Ac Anti IgM o Ac Total | 20 | — | 09/2026 |
| 1035 | HDL COLESTEROL (HDL-C) | 3 | — | 09/2026 |
| 1040 | LDL COLESTEROL (LDL-C) | 4 | — | 09/2026 |
| 1050 | DROGAS DE ABUSO, Screening c/u | 17.5 | — | 09/2026 |
| 1055 | EPSTEIN BARR, AC. Anti IgG o Ac. Totales | 15 | — | 09/2026 |
| 1060 | EPSTEIN BARR, AC. Anti IgM | 20 | — | 09/2026 |
| 1065 | FRUCTOSAMINA | 15 | — | 09/2026 |
| 1100 | HIDATIDOSIS, DOBLE INMUNOELECTROFORESIS | 22 | — | 09/2026 |
| 1135 | MONIT. DE FARMACO /ENF. CRONICAS (ANTICO | 15 | 6 Anual | 09/2026 |
| 1136 | MONIT. DE FARMACO /ENF. CRONICA (CAFEINA | 24 | 6 Anual | 09/2026 |
| 1137 | MONITOREO DE FARMACOS para ENF.CRONICAS | 60 | 6 Anual | 09/2026 |
| 1140 | MYCOPLASMA PNEUMONIA Ac. Anti IgG | 18 | 3 Anual | 09/2026 |
| 1145 | RUBEOLA Ac IgG Anti | 15 | 3 Anual | 09/2026 |
| 1150 | RUBEOLA Ac IgM Anti | 15 | 3 Anual | 09/2026 |
| 1180 | TEST RAPIDO en FAUCES para Streptococcus | 12.5 | — | 09/2026 |
| 1185 | TESTOSTERONA BIODISPONIBLE | 25 | 2 Anual | 09/2026 |
| 1194 | SCEENING NEONATAL x 2 (TSH, FENIL ALANIN | 13 | — | 09/2026 |
| 1195 | SCREENING NEONATAL x 4 ( BIOTINIDASA, TI | 30 | — | 09/2026 |
| 1196 | SCREENING NEONATAL x 6 TSH FENIL | 46 | — | 09/2026 |
| 2000 | ANTI HBC | 15 | 2 Anual | 09/2026 |
| 2001 | ANTI HBC/Ag.EC | 15 | 2 Anual | 09/2026 |
| 2002 | ANTI HVA (IgG o IgM) | 15 | 2 Anual | 09/2026 |
| 2003 | ANTI HBS | 20 | 2 Anual | 09/2026 |
| 2004 | HEPATITIS "C" | 20 | 2 Anual | 09/2026 |
| 2006 | CPK-MB | 10 | 3 Anual | 09/2026 |
| 2007 | FRUCTOSAMINA O HEMOGLOBINA GLICOSILADA | 15 | — | 09/2026 |
| 2008 | Ca-19-9 | 20 | — | 09/2026 |
| 2009 | Ca-15-3 | 20 | — | 09/2026 |
| 2010 | Ca 125 | 20 | — | 09/2026 |
| 2011 | PSA (AntÝgeno Frostßtico Especifico) | 18 | — | 09/2026 |
| 2012 | BHCG | 14 | — | 09/2026 |
| 2013 | FERRITINA | 15 | — | 09/2026 |
| 2014 | ANTIGENO AUSTRALIANO-ELISA | 12 | 2 Anual | 09/2026 |
| 2015 | MICROALBUMINURIA | 12.5 | — | 09/2026 |
| 2016 | CONTROL MENSUAL | 25 | — | 09/2026 |
| 2017 | CONTROL TRIMESTRAL | 44 | — | 09/2026 |
| 2018 | CONTROL SEMESTRAL | 126.5 | — | 09/2026 |
| 2019 | CONTROL ANUAL | 157.5 | — | 09/2026 |
| 2020 | ANTIGENO PROSTATICO ESPECIFICO | 18 | — | 09/2026 |
| 2021 | CD4 | 35 | — | 09/2026 |
| 2022 | CD8 | 35 | — | 09/2026 |
| 2023 | CARGA VIRAL | 160 | — | 09/2026 |
| 2024 | HIV RT PCR | 80 | — | 09/2026 |
| 2025 | ANTICUERPOS ANTIENDOMICIO IGA EMA | 14 | 2 Anual | 09/2026 |
| 2026 | ANTITRANSGLUTAMIDASA TISULAR IGA | 23 | — | 09/2026 |
| 2027 | TROPONINA | 25 | — | 09/2026 |
| 2028 | ANTICUERPOS ANTIENDOMICIO IGA EMA | 14 | — | 09/2026 |
| 2029 | ANTITRANSGLUTAMIDASA TISULAR IGA | 23 | — | 09/2026 |
| 2030 | SANGRE OCULTA EN MATERIA FECAL | 8 | — | 09/2026 |
| 2031 | ACETILCOLINA, Ac. Anti-RECEPTORES(ACRA) | 100 | — | 09/2026 |
| 2073 | MODULO ATIPICO | 1 | — | 09/2026 |
| 2119 | ACIDO CITRICO-Plasmatico | 15 | — | 09/2026 |
| 2120 | ACIDO CITRICO-Urinario | 15 | — | 09/2026 |
| 2299 | ACIDO OXALICO-Urinario(2/12/24 hs)-c/uno | 15 | 3 Anual | 09/2026 |
| 2367 | ACIDO BILIARES- Sericos | 30 | — | 09/2026 |
| 2675 | ANDROSTENEDIONA DELTA 4 | 12 | 2 Anual | 09/2026 |
| 2709 | ANTICOAGULANTE LUPICO | 30 | — | 09/2026 |
| 2712 | HAD (hormona antidiuretica) | 85 | — | 09/2026 |
| 2790 | ANTIMULLERIANA, HORMONA (HAM) | 75 | 2 Anual | 09/2026 |
| 2803 | Antirombina III Funcional | 25 | — | 09/2026 |
| 2846 | ASPERGILLIUS-Ac. Anti- | 24 | — | 09/2026 |
| 2863 | Bandas Oligoclonales LCR/suero | 220 | — | 09/2026 |
| 2914 | Bartolnella henselae Ig M | 50 | — | 09/2026 |
| 2980 | Beta 2 GLICOPROTEINA, Ac.Ig A anti - | 30 | — | 09/2026 |
| 2982 | Beta 2 GLICOPROTEINA, Ac.Ig G anti- | 30 | — | 09/2026 |
| 2984 | Beta 2 GLICOPROTEINA, Ac. Ig M anti- | 30 | — | 09/2026 |
| 3025 | BETA CROSS LAPS - TELOPEPTIDO DE COLAGEN | 32 | 2 Anual | 09/2026 |
| 3056 | Beta-HCG libre | 14 | 24 Anual | 09/2026 |
| 3093 | BNP (Factor Natriuretico)/Pro BNP-(NT-Pr | 95 | 1 Anual | 09/2026 |
| 3141 | BRCA 1 BRCA 2, GRANDES DELECCIONES Y DUP | 1000 | — | — |
| 3255 | Cadenas livianas libres | 130 | 2 Anual | 09/2026 |
| 3310 | Calpropectina en heces | 100 | 1 Anual | 09/2026 |
| 3384 | CARDIOLIPINA AC IGA ANTI | 20 | 2 Anual | 09/2026 |
| 3392 | CARDIOLIPINA AC IGG ANTI | 18 | 2 Anual | 09/2026 |
| 3401 | CARDIOLIPINA AC IGM ANTI | 18 | 2 Anual | 09/2026 |
| 3430 | CARIOTIPO, con BANDEO | 140 | 1 en vida | 09/2026 |
| 3563 | CENTROMERO, Ac. Anti- | 22 | 2 Anual | 09/2026 |
| 3589 | Chlamidya Pneumoniae Ig. M | 20 | — | 09/2026 |
| 3640 | CHLAMYDIA TRACHOMATIS, Ag | 20 | — | 09/2026 |
| 3674 | Ciclosporina A | 30 | 4 Anual | 09/2026 |
| 3722 | CMV PCR Cualitativa | 70 | — | 09/2026 |
| 3734 | ANCA C,P c/u | 28 | 2 Anual | 09/2026 |
| 3762 | Clostridium difficille Tox.A y B | 100 | — | 09/2026 |
| 3860 | COCCIDIODES INMITIS, Ac.Ig Totales Anti- | 40 | — | 09/2026 |
| 3976 | SARS-Cov-2 Ag - Test rápido | 38 | — | 09/2026 |
| 3978 | SARS-Cov-2 RT-PCR | 93 | — | 09/2026 |
| 4008 | CORTISOL LIBRE-URINARIO CLU | 12 | 3 Anual | 09/2026 |
| 4141 | CROMOGRANINA A | 150 | 2 Anual | 09/2026 |
| 4264 | CRYPTOCOCCUS NEOFORMANS, Ag. | 40 | — | 09/2026 |
| 4266 | CRYPTOCOCCUS NEOFORMANS, (Microscopia Ti | 8 | — | 09/2026 |
| 4290 | CUERPOS REDUCTORES | 7 | 2 Anual | 09/2026 |
| 4375 | DEOXIPIRIDIOLINAS (DPD) | 28 | — | 09/2026 |
| 4418 | DIMERO D | 35 | 2 Anual | 09/2026 |
| 4600 | Elastasa pancreatica | 120 | — | 09/2026 |
| 4734 | ERITROPOYETINA (EPO) | 45 | — | 09/2026 |
| 4858 | ESPERMOGRAMA COMPLETO | 28 | 1 Anual | 09/2026 |
| 4930 | Esperma, selección de gradientes (insemi | 100 | 1 Anual | 09/2026 |
| 4964 | Esperma, Fragmentación de ADN espermátic | 110 | 1 Anual | 09/2026 |
| 4999 | ESTEATOCRITO( Grasas- materia fecal) | 9 | — | 09/2026 |
| 5053 | Everolimus | 90 | — | 09/2026 |
| 5085 | Factor Intrínseco Ac.Anti | 55 | — | 09/2026 |
| 5102 | Factor V de Leyden | 75 | — | 09/2026 |
| 5116 | Factor Von Willebrand, Funcional/Cofacto | 70 | — | 09/2026 |
| 5119 | Factor Von Willebrand (Inmunológico) | 60 | — | 09/2026 |
| 5298 | EFK-506 TACROLIMUS | 60 | — | 09/2026 |
| 5452 | FOSFOPLIPIDOS Ac. Ig G Anti- | 20 | — | 09/2026 |
| 5461 | FOSFOPLIDIDOS Ac. Ig M Anti- | 20 | — | 09/2026 |
| 5465 | FOSFOLIPIDOS AC TOTALES (IGA-IGM-IGG) | 25 | — | 09/2026 |
| 5478 | FRUCTOSA, Liquido seminal o serico o uri | 10 | — | 09/2026 |
| 5503 | GAD, Ac. Anti | 45 | — | 09/2026 |
| 5572 | GLIADINA, Ac IgA Anti- (AGA-IgA) | 14 | — | 09/2026 |
| 5583 | GLIADINA, Ac. IgG Anti-PEPTIDO DEAMINADO | 24 | 2 Anual | 09/2026 |
| 5632 | GLAE/SHBG | 22 | 1 Anual | 09/2026 |
| 5778 | Helicobacter pylori Ag, materia fecal | 21 | 1 Anual | 09/2026 |
| 5797 | Hemocultivo Automatizado (c/U) (aerobios | 25 | — | 09/2026 |
| 5871 | Heparina Actividad Anti Xa | 40 | — | 09/2026 |
| 5905 | Hepatitis B, Ac. Anti- "Core" IgM (HBcM) | 18 | 2 Anual | 09/2026 |
| 5914 | HEPATITIS ¿B¿, Carga Viral | 185 | 2 Anual | 09/2026 |
| 5956 | HEPATITIS C, Carga viral (PCR) | 185 | 2 Anual | 09/2026 |
| 5965 | HCV Genotipo PCR | 135 | — | 09/2026 |
| 5982 | HCV RNA cualitativo PCR | 120 | 1Anual | 09/2026 |
| 6037 | Herpes Simplex 1/2 PCR | 90 | 1 Anual | 09/2026 |
| 6042 | HERPES SIMPLEX 1 Ac.G o Totales Anti. | 19 | 2 Anual | 09/2026 |
| 6050 | HERPES SIMPLEX 1 Ac. M Anti. | 19 | 2 Anual | 09/2026 |
| 6067 | HERPES SIMPLEX 2 Ac.G o Totales Anti. | 19 | 2 Anual | 09/2026 |
| 6247 | HISTOPLASMA CAPSULATUM, Ac. IgG Anti- | 24 | — | 09/2026 |
| 6255 | HISTOPLASMA CAPSULATUM, Ac.IgM Anti- | 24 | — | 09/2026 |
| 6281 | HIV - Resistencia a Antiretrovirales | 400 | — | 09/2026 |
| 6452 | Homocisteina | 30 | 1 Anual | 09/2026 |
| 6560 | IA2, Ac Anti/ICA 512 Ac Anti | 50 | — | 09/2026 |
| 6589 | Ig A BC-saliva | 6 | 2 Anual | 09/2026 |
| 6606 | Ig E especifica c/u | 13 | 3 Anual | 09/2026 |
| 6848 | INMUNOFIJACION-LCR | 50 | — | 09/2026 |
| 6850 | INMUNOFIJACION-Serica | 50 | — | 09/2026 |
| 6852 | INMUNOFIJACION-Urinaria | 50 | — | 09/2026 |
| 6862 | INSULINA,Ac.Anti-(Ac.Anti IAA) | 35 | — | 09/2026 |
| 6905 | ICA, Ac. Anti-ISLOTES LANGERHANS PANCREA | 25 | — | 09/2026 |
| 6912 | JO-1, Ac. Anti- | 25 | — | 09/2026 |
| 6930 | LA, Ac. Anti-(LA/SSB) | 15 | — | 09/2026 |
| 7262 | LKM, Ac. Anti- | 20 | — | 09/2026 |
| 7289 | Macroprolactina | 30 | — | 09/2026 |
| 7503 | Microglobulina B2 | 18 | — | 09/2026 |
| 7614 | Mucosa Gástrica Ac. Anti (Celulas Pariet | 19 | — | 09/2026 |
| 7636 | Musk Ac. Anti | 220 | — | 09/2026 |
| 7700 | MYCOPLASMA-UREAPLASMA, Cultivo | 25 | — | 09/2026 |
| 7708 | Mycoplasma hominis cultivo | 25 | — | 09/2026 |
| 7717 | Mycoplasma pneumoniae Ig. M | 18 | — | 09/2026 |
| 8018 | PAPP-A (Proteina A plasmatica asociada a | 40 | 1 Anual | 09/2026 |
| 8127 | PARACOCCIDIODES SPP, Ac. Anti-Totales | 29 | — | 09/2026 |
| 8281 | PEPTIDO C | 18 | — | 09/2026 |
| 8284 | PEPTIDO CITRULINADO | 50 | 2 Anual | 09/2026 |
| 8563 | Procalcitonina | 75 | — | 09/2026 |
| 8580 | PROGESTERONA 17 - OH (17-OH-Pg) | 15 | 2 Anual | 09/2026 |
| 8614 | Proteina C Funcional | 45 | — | 09/2026 |
| 8631 | Proteina S Fracción Libre | 45 | — | 09/2026 |
| 8648 | Proteina S Fracional | 85 | — | 09/2026 |
| 8691 | Protrombina 20210 | 75 | — | 09/2026 |
| 8802 | RECEPTOR de TSH, Ac. Anti(TRABs) | 40 | 2 Anual | 09/2026 |
| 8828 | Proteina C Activada Resistencia | 35 | 1 Anual | 09/2026 |
| 8896 | RNP Ac. Anti ( RIBONUCLEOPROTEINAS) | 16 | 2 Anual | 09/2026 |
| 8905 | Ro, Ac.Anti-(Ro/SSA) | 15 | 2 Anual | 09/2026 |
| 8999 | SCLERODERMIA-SCL70, Ac. Anti- | 20 | 2 Anual | 09/2026 |
| 9101 | SINDROMES LINFOPROLIFERATIVOS-FENOTIPIFI | 300 | — | 09/2026 |
| 9102 | JAK 2 Mutación | 300 | — | 09/2026 |
| 9105 | Sirolimus | 70 | 2 Anual | 09/2026 |
| 9110 | SM Ac. Anti- | 15 | — | 09/2026 |
| 9118 | SOMATOMEDINA C-IGFB1 | 35 | 2 Anual | 09/2026 |
| 9120 | SOMATOMEDINA C-IGFB3 | 60 | 2 Anual | 09/2026 |
| 9127 | STREPTOCACCUS BETA-EMOLITICO GRUPO B PRE | 18 | — | 09/2026 |
| 9375 | TESTOSTERONA LIBRE | 15 | 2 Anual | 09/2026 |
| 9443 | TIROGLOBULINA (TGs) | 15 | 3 Anual | 09/2026 |
| 9511 | Toxocara cannis Ig G | 26 | — | 09/2026 |
| 9514 | Toxocara cannis Ig M | 30 | — | 09/2026 |
| 9538 | Toxoide tetánico | 90 | 1 Anual | 09/2026 |
| 9580 | INMUNOGLOBULINA M para TOXOPLAS (ELISA) | 14 | 2 Anual | 09/2026 |
| 9588 | INMUNOGLOBULINA M para TOXOPLASMOSIS IFI | 10 | 2 Anual | 09/2026 |
| 9642 | BCR/ABL P210 | 360 | 1 Anual | 09/2026 |
| 9834 | Varicela Zoster PCR | 70 | — | 09/2026 |
| 9913 | VITAMINA D3 (25 HIDROXICALCIFEROL) | 37 | 2 Anual | 09/2026 |
Datos actualizados el 29/09/2026 a las 23:10 hs desde el sistema del Colegio.